High-throughput screening (HTS) assay is a method used in drug discovery and other fields to quickly and efficiently test a large number of compounds or samples for a specific biological activity. HTS assays are typically automated and can screen thousands to millions of compounds in a relatively short amount of time. HTS assays are often used in the early stages of drug discovery to identify potential lead compounds that show promising activity against a target of interest. These assays can be used to screen for a wide range of biological activities, such as enzyme inhibition, receptor binding, or cell-based assays. There are several different types of HTS assays, including biochemical assays, cell-based assays, and phenotypic assays. Biochemical assays measure the activity of a specific enzyme or protein, while cell-based assays use living cells to measure the effect of compounds on cellular processes. Phenotypic assays measure a specific observable phenotype, such as cell growth or morphology. Overall, HTS assays are a powerful tool in drug discovery and other fields, allowing researchers to quickly and efficiently screen large libraries of compounds to identify potential drug candidates.
The global High-throughput Screening (HTS) Assay market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for High-throughput Screening (HTS) Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for High-throughput Screening (HTS) Assay is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for High-throughput Screening (HTS) Assay in Drug Discovery is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of High-throughput Screening (HTS) Assay include Thermo Fisher Scientific, PerkinElmer, Agilent Technologies, Beckman Coulter, Tecan Group, Hamilton Company, Bio-Rad Laboratories, BMG LABTECH, Promega Corporation, Danaher, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for High-throughput Screening (HTS) Assay, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High-throughput Screening (HTS) Assay.
The High-throughput Screening (HTS) Assay market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global High-throughput Screening (HTS) Assay market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the High-throughput Screening (HTS) Assay companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio-Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical
Segment by Type
Biochemical Assay
Phenotyping Assay
Binding Assay
Aell-based Assay
Others
Segment by Application
Drug Discovery
Identifying New Drug Targets
Toxicology Research
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of High-throughput Screening (HTS) Assay company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-throughput Screening (HTS) Assay Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Biochemical Assay
1.2.3 Phenotyping Assay
1.2.4 Binding Assay
1.2.5 Aell-based Assay
1.2.6 Others
1.3 Market by Application
1.3.1 Global High-throughput Screening (HTS) Assay Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug Discovery
1.3.3 Identifying New Drug Targets
1.3.4 Toxicology Research
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-throughput Screening (HTS) Assay Market Perspective (2019-2030)
2.2 Global High-throughput Screening (HTS) Assay Growth Trends by Region
2.2.1 Global High-throughput Screening (HTS) Assay Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 High-throughput Screening (HTS) Assay Historic Market Size by Region (2019-2024)
2.2.3 High-throughput Screening (HTS) Assay Forecasted Market Size by Region (2025-2030)
2.3 High-throughput Screening (HTS) Assay Market Dynamics
2.3.1 High-throughput Screening (HTS) Assay Industry Trends
2.3.2 High-throughput Screening (HTS) Assay Market Drivers
2.3.3 High-throughput Screening (HTS) Assay Market Challenges
2.3.4 High-throughput Screening (HTS) Assay Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-throughput Screening (HTS) Assay Players by Revenue
3.1.1 Global Top High-throughput Screening (HTS) Assay Players by Revenue (2019-2024)
3.1.2 Global High-throughput Screening (HTS) Assay Revenue Market Share by Players (2019-2024)
3.2 Global High-throughput Screening (HTS) Assay Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by High-throughput Screening (HTS) Assay Revenue
3.4 Global High-throughput Screening (HTS) Assay Market Concentration Ratio
3.4.1 Global High-throughput Screening (HTS) Assay Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-throughput Screening (HTS) Assay Revenue in 2023
3.5 Global Key Players of High-throughput Screening (HTS) Assay Head office and Area Served
3.6 Global Key Players of High-throughput Screening (HTS) Assay, Product and Application
3.7 Global Key Players of High-throughput Screening (HTS) Assay, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 High-throughput Screening (HTS) Assay Breakdown Data by Type
4.1 Global High-throughput Screening (HTS) Assay Historic Market Size by Type (2019-2024)
4.2 Global High-throughput Screening (HTS) Assay Forecasted Market Size by Type (2025-2030)
5 High-throughput Screening (HTS) Assay Breakdown Data by Application
5.1 Global High-throughput Screening (HTS) Assay Historic Market Size by Application (2019-2024)
5.2 Global High-throughput Screening (HTS) Assay Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America High-throughput Screening (HTS) Assay Market Size (2019-2030)
6.2 North America High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
6.4 North America High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High-throughput Screening (HTS) Assay Market Size (2019-2030)
7.2 Europe High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
7.4 Europe High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific High-throughput Screening (HTS) Assay Market Size (2019-2030)
8.2 Asia-Pacific High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region (2019-2024)
8.4 Asia-Pacific High-throughput Screening (HTS) Assay Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America High-throughput Screening (HTS) Assay Market Size (2019-2030)
9.2 Latin America High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
9.4 Latin America High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-throughput Screening (HTS) Assay Market Size (2019-2030)
10.2 Middle East & Africa High-throughput Screening (HTS) Assay Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Country (2019-2024)
10.4 Middle East & Africa High-throughput Screening (HTS) Assay Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific High-throughput Screening (HTS) Assay Introduction
11.1.4 Thermo Fisher Scientific Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer High-throughput Screening (HTS) Assay Introduction
11.2.4 PerkinElmer Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.2.5 PerkinElmer Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies High-throughput Screening (HTS) Assay Introduction
11.3.4 Agilent Technologies Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.3.5 Agilent Technologies Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter High-throughput Screening (HTS) Assay Introduction
11.4.4 Beckman Coulter Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.4.5 Beckman Coulter Recent Development
11.5 Tecan Group
11.5.1 Tecan Group Company Details
11.5.2 Tecan Group Business Overview
11.5.3 Tecan Group High-throughput Screening (HTS) Assay Introduction
11.5.4 Tecan Group Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.5.5 Tecan Group Recent Development
11.6 Hamilton Company
11.6.1 Hamilton Company Company Details
11.6.2 Hamilton Company Business Overview
11.6.3 Hamilton Company High-throughput Screening (HTS) Assay Introduction
11.6.4 Hamilton Company Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.6.5 Hamilton Company Recent Development
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories High-throughput Screening (HTS) Assay Introduction
11.7.4 Bio-Rad Laboratories Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.7.5 Bio-Rad Laboratories Recent Development
11.8 BMG LABTECH
11.8.1 BMG LABTECH Company Details
11.8.2 BMG LABTECH Business Overview
11.8.3 BMG LABTECH High-throughput Screening (HTS) Assay Introduction
11.8.4 BMG LABTECH Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.8.5 BMG LABTECH Recent Development
11.9 Promega Corporation
11.9.1 Promega Corporation Company Details
11.9.2 Promega Corporation Business Overview
11.9.3 Promega Corporation High-throughput Screening (HTS) Assay Introduction
11.9.4 Promega Corporation Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.9.5 Promega Corporation Recent Development
11.10 Danaher
11.10.1 Danaher Company Details
11.10.2 Danaher Business Overview
11.10.3 Danaher High-throughput Screening (HTS) Assay Introduction
11.10.4 Danaher Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.10.5 Danaher Recent Development
11.11 Axxam
11.11.1 Axxam Company Details
11.11.2 Axxam Business Overview
11.11.3 Axxam High-throughput Screening (HTS) Assay Introduction
11.11.4 Axxam Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.11.5 Axxam Recent Development
11.12 Merck Millipore
11.12.1 Merck Millipore Company Details
11.12.2 Merck Millipore Business Overview
11.12.3 Merck Millipore High-throughput Screening (HTS) Assay Introduction
11.12.4 Merck Millipore Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.12.5 Merck Millipore Recent Development
11.13 Aurora Biomed
11.13.1 Aurora Biomed Company Details
11.13.2 Aurora Biomed Business Overview
11.13.3 Aurora Biomed High-throughput Screening (HTS) Assay Introduction
11.13.4 Aurora Biomed Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.13.5 Aurora Biomed Recent Development
11.14 InvivoGen
11.14.1 InvivoGen Company Details
11.14.2 InvivoGen Business Overview
11.14.3 InvivoGen High-throughput Screening (HTS) Assay Introduction
11.14.4 InvivoGen Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.14.5 InvivoGen Recent Development
11.15 Biotek Instruments
11.15.1 Biotek Instruments Company Details
11.15.2 Biotek Instruments Business Overview
11.15.3 Biotek Instruments High-throughput Screening (HTS) Assay Introduction
11.15.4 Biotek Instruments Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.15.5 Biotek Instruments Recent Development
11.16 BPS Bioscience
11.16.1 BPS Bioscience Company Details
11.16.2 BPS Bioscience Business Overview
11.16.3 BPS Bioscience High-throughput Screening (HTS) Assay Introduction
11.16.4 BPS Bioscience Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.16.5 BPS Bioscience Recent Development
11.17 Eurofins Discovery
11.17.1 Eurofins Discovery Company Details
11.17.2 Eurofins Discovery Business Overview
11.17.3 Eurofins Discovery High-throughput Screening (HTS) Assay Introduction
11.17.4 Eurofins Discovery Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.17.5 Eurofins Discovery Recent Development
11.18 Cayman Chemical
11.18.1 Cayman Chemical Company Details
11.18.2 Cayman Chemical Business Overview
11.18.3 Cayman Chemical High-throughput Screening (HTS) Assay Introduction
11.18.4 Cayman Chemical Revenue in High-throughput Screening (HTS) Assay Business (2019-2024)
11.18.5 Cayman Chemical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Thermo Fisher Scientific
PerkinElmer
Agilent Technologies
Beckman Coulter
Tecan Group
Hamilton Company
Bio-Rad Laboratories
BMG LABTECH
Promega Corporation
Danaher
Axxam
Merck Millipore
Aurora Biomed
InvivoGen
Biotek Instruments
BPS Bioscience
Eurofins Discovery
Cayman Chemical
听
听
*If Applicable.
